Advertisement

Topics

Inflammatory Bowel Disease IBD Drugs

13:09 EST 21st January 2019 | BioPortfolio

Humira [AbbVie Inc.]

These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescribing information for HUMIRA. HUMIRA (adalimumab) injection, for subcutaneous useInitial U.S. Approval: 2002

Dipentum [Carilion Materials Management]

Dipentum (olsalazine sodium capsules)

Entyvio [Takeda Pharmaceuticals America, Inc.]

These highlights do not include all the information needed to use ENTYVIO safely and effectively. See full prescribing information for ENTYVIO.ENTYVIO (vedolizumab) for injection, for intravenous use Initial U.S. Approval: 2014

Humira [A-S Medication Solutions]

These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescribing information for HUMIRA. HUMIRA (adalimumab) injection, for subcutaneous useInitial U.S. Approval: 2002

Pentasa [Avera McKennan Hospital]

PENTASA (mesalamine) Controlled-Release Capsules 250 mg Prescribing Information as of 10/2015 Rx only

Dipentum [Carilion Materials Management]

Dipentum (olsalazine sodium)capsule, gelatin coated Rx OnlyCIP70006APT#CIA60342Rev. 1/2014 CIP70006A

Pentasa [Carilion Materials Management]

PENTASA (mesalamine) Controlled-Release Capsules 250 mg and 500 mg Prescribing Information as of 10/2015 Rx only

Dipentum (olsalazine sodium capsules) [UCB, Inc.]

DIPENTUM (olsalazine sodium capsules)

Pentasa [Shire US Manufacturing Inc.]

PENTASA (mesalamine) Controlled-Release Capsules 250 mg and 500 mg Prescribing Information as of 5/2018 Rx only

Taltz [Eli Lilly and Company]

These highlights do not include all the information needed to use TALTZ safely and effectively. See full prescribing information for TALTZ.TALTZ (ixekizumab) injection, for subcutaneous useInitial U.S. Approval: 2016

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy Inflammatory Bowel Disease IBD market research data and corporate reports here